Precision Nutrition to optimize immune response for metabolic health
NUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies.
Projectdetails
Introduction
NUTRIMMUNE examines how dietary factors affect immune responses across varying degrees of obesity-related Noncommunicable Disease (NCD) severity. This focus is crucial given obesity’s link to NCDs and infection risks. The project gathers 6 academic groups and 1 SME across 4 European countries over 4 years and a €4.3M grant to evaluate the interplay between nutrition, glycome, microbiome, and immune health in obesity and immune impairment.
Project Partners
NUTRIMMUNE leverages partners:
- Access to European databases and biobanks, enabling in-depth analysis at cellular and molecular levels.
- Proficiency in conducting dietary intervention studies in human subjects.
- Experience in mechanistic and functional diet-glycome-microbiome interactions.
Work Packages
WP1: Phenotypic and Multi-Omics Analysis
In WP1, the project deciphers phenotypic, multi-omics, and dietary factors responsible for variability in Immune Checkpoint (ICP) expression and immune impairment in existing cohorts.
WP2: Nutritional Intervention
WP2 focuses on a 24-week precision nutritional intervention to assess the potential of a pro-immune diet to restore T cell fitness in obese subjects.
WP3: Comprehensive Profiling
WP3 conducts comprehensive profiling before and after the dietary intervention, examining innate and adaptive responses, cytokine patterns, alongside ICP labeling.
WP4: Mechanistic Insights
WP4 provides mechanistic aspects on how the diet, glycome, and microbiome influence immune health.
WP5: Machine Learning Models
WP5 employs machine learning models to identify predictive markers and signatures for ICP expression and altered immunity, to identify dietary patterns and food affecting immune function.
WP6: Project Management
WP6 ensures efficient project management and effective coordination, ethics compliance, dissemination, and exploitation.
WP7: Synergies Exploration
WP7 explores synergies with portfolio projects for challenge goals.
Project Goal
The project’s goal is to move from our novel idea that precision nutrition influences immunity via microbiome and glycome, and present validated proof-of-concept evidence for nutritional recommendations and future food development.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 4.318.432 |
Totale projectbegroting | € 4.318.432 |
Tijdlijn
Startdatum | 1-9-2024 |
Einddatum | 31-8-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- SORBONNE UNIVERSITEpenvoerder
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- STICHTING AMSTERDAM UMC
- UNIVERSITAET HOHENHEIM
- LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-INSTITUT
- INTEGRATIVE PHENOMICS
- UNIVERSITAET BERN
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Development of nutritional vesicles for precision diagnostics and therapeutics for metabolic diseasesThe NutriEV project investigates food-derived extracellular vesicles as superfoods and biosensors to enhance gut health and metabolic regulation through innovative research and non-invasive biomonitoring. | EIC Pathfinder | € 3.943.243 | 2024 | Details |
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout PreventionThis project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses. | EIC Pathfinder | € 3.765.840 | 2024 | Details |
Understanding the potential of modulating Host-Microbiome-Glycan interactions (“the triangle of sweetness”) to tackle non-communicable diseasesThe project aims to identify novel glycosyltransferases and HMOs, analyze their gut interactions, and validate an HMO for inflammation relief, enhancing glycobiology research and therapeutic applications. | EIC Pathfinder | € 3.920.718 | 2024 | Details |
Addressing malnutrition and metabolic health in non-communicable diseases through precision Nutrition: impact in quality of life and prognosis of lung cancer patients.MENTORING aims to improve the nutritional and metabolic health of lung cancer patients through personalized dietary plans based on multi-omics approaches, enhancing quality of life and treatment outcomes. | EIC Pathfinder | € 4.031.666 | 2024 | Details |
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sourcesFIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS. | EIC Pathfinder | € 3.449.447 | 2024 | Details |
Development of nutritional vesicles for precision diagnostics and therapeutics for metabolic diseases
The NutriEV project investigates food-derived extracellular vesicles as superfoods and biosensors to enhance gut health and metabolic regulation through innovative research and non-invasive biomonitoring.
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention
This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.
Understanding the potential of modulating Host-Microbiome-Glycan interactions (“the triangle of sweetness”) to tackle non-communicable diseases
The project aims to identify novel glycosyltransferases and HMOs, analyze their gut interactions, and validate an HMO for inflammation relief, enhancing glycobiology research and therapeutic applications.
Addressing malnutrition and metabolic health in non-communicable diseases through precision Nutrition: impact in quality of life and prognosis of lung cancer patients.
MENTORING aims to improve the nutritional and metabolic health of lung cancer patients through personalized dietary plans based on multi-omics approaches, enhancing quality of life and treatment outcomes.
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sources
FIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
RESTORING IMMUNITY CONTROL OF GI CANCERSTIMNano aims to develop a novel cancer immunotherapy platform using targeted biodegradable nanoparticles to enhance immune responses against gastrointestinal cancers, progressing through clinical trials and commercialization. | EIC Transition | € 2.007.750 | 2025 | Details |
Microbiome-based diagnostics and therapeuticsThis project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression. | ERC Proof of... | € 150.000 | 2023 | Details |
Multidimensional in vivo metabolic flux analyses: Resolving immune cells based on in vivo metabolic phenotypesThe project aims to develop a novel nutrient uptake assay for analyzing immune cell metabolism in vivo, enhancing immunotherapy design for solid tumors through detailed metabolic insights. | ERC Proof of... | € 150.000 | 2023 | Details |
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutritionThe InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Illuminating the Dark MicroProteome in Innate ImmunityMicroIMMUNE aims to uncover the microproteome in innate immune cells using computational and synthetic biology to explore their functions and interactions, potentially revolutionizing immune response understanding. | ERC Starting... | € 1.500.000 | 2025 | Details |
RESTORING IMMUNITY CONTROL OF GI CANCERS
TIMNano aims to develop a novel cancer immunotherapy platform using targeted biodegradable nanoparticles to enhance immune responses against gastrointestinal cancers, progressing through clinical trials and commercialization.
Microbiome-based diagnostics and therapeutics
This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.
Multidimensional in vivo metabolic flux analyses: Resolving immune cells based on in vivo metabolic phenotypes
The project aims to develop a novel nutrient uptake assay for analyzing immune cell metabolism in vivo, enhancing immunotherapy design for solid tumors through detailed metabolic insights.
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition
The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.
Illuminating the Dark MicroProteome in Innate Immunity
MicroIMMUNE aims to uncover the microproteome in innate immune cells using computational and synthetic biology to explore their functions and interactions, potentially revolutionizing immune response understanding.